Related Experiment Video

Updated: Aug 6, 2026

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Expansion of IL-10-producing CD4+ and CD8+ T cells in fixed drug eruption

Yuichi Teraki1, Tomoko Kokaji, Tetsuo Shiohara

  • 1Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan. teraki@saitama-med.ac.jp

Dermatology (Basel, Switzerland)
|August 12, 2006
PubMed
Abstract

Insights

Severe fixed drug eruption (FDE) resolved spontaneously. Increased interleukin-10 (IL-10) producing T cells, specifically CD4+ and CD8+ T cells, may drive this resolution without corticosteroids.

Area of Science:

  • Immunology
  • Dermatology

Background:

  • Fixed drug eruption (FDE) can mimic toxic epidermal necrolysis (TEN).
  • Unlike TEN, FDE resolves spontaneously after drug cessation.

Observation:

  • A severe case of FDE caused by mefenamic acid resolved without systemic corticosteroids.
  • T cell cytokine production was analyzed before and after drug challenge.

Findings:

  • Interleukin-10 (IL-10) producing CD4+ and CD8+ T cells significantly increased post-challenge.
  • Gamma-interferon (IFN-γ) and Interleukin-4 (IL-4) producing T cells remained unchanged.
  • Interleukin-2 (IL-2) producing CD8+ T cells decreased post-challenge.

Implications:

  • Expansion of IL-10 producing CD4+ and CD8+ T cells may mediate spontaneous FDE resolution.
  • This finding offers insights into the immunologic mechanisms of FDE resolution.

More Related Videos

Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester07:00

Quantification of Proliferating Human Antigen-specific CD4+ T Cells using Carboxyfluorescein Succinimidyl Ester

Published on: June 4, 2019

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...